Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.03.31.646336

NeSyDPP4-QSAR: A Neuro-Symbolic AI Approach for Potent DPP-4-Inhibitor Discovery in Diabetes Treatment

Abstract

Diabetes Mellitus (DM) is a global epidemic and among the top ten leading causes of mortality (WHO, 2019), projected to rank seventh by 2030. The US National Diabetes Statistics Report (2021) states that 38.4 million Americans have diabetes. Dipeptidyl Peptidase-4 (DPP-4) is an FDA-approved target for type 2 diabetes mellitus (T2DM) treatment. However, current DPP-4 inhibitors are associated with adverse effects, including gastrointestinal issues, severe joint pain (FDA safety warning), nasopharyngitis, hypersensitivity, and nausea. Identifying novel inhibitors is crucial. Direct in vivo DPP-4 inhibition assessment is costly and impractical, making in silico IC50 prediction a viable alternative. Quantitative Structure-Activity Relationship (QSAR) modeling is a widely used computational approach for chemical substance assessment. We employ LTN, a neuro-symbolic approach, alongside DNN and transformers as baselines. DPP-4-related data is sourced from PubChem, ChEMBL, BindingDB, and GTP, comprising 6,563 bioactivity records (SMILES-based compounds with IC50 values) after deduplication and thresholding. A diverse set of features including descriptors (CDK Extended-PaDEL), fingerprints (Morgan), chemical language model embeddings (ChemBERTa2), LLaMa 3.2, and physicochemical properties is used to train the NeSyDPP4-QSAR model. The NeSyDPP4-QSAR model yielded the highest accuracy, incorporating CDKextended and Morgan fingerprints, with an accuracy of 0.9725, an F1-score of 0.9723, an ROC AUC of 0.9719, and an MCC of 0.9446. The performance was benchmarked against two standard baseline models: a deep neural network and a transformer. To ensure fair comparisons, DNN models used the equivalent attributes with the same dimension and network configuration as NeSyDPP4-QSAR. Our findings showed that integrating the Neuro-symbolic strategy (neural network-based learning and symbolic reasoning) holds immense potential for discovering drugs that can inhibit diabetes mellitus and classifying biological activities that inhibit it.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hossain, D., Chen, J. Y.. 2025-04-05. NeSyDPP4-QSAR: A Neuro-Symbolic AI Approach for Potent DPP-4-Inhibitor Discovery in Diabetes Treatment. https://doi.org/10.1101/2025.03.31.646336

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Inferring cascade drivers of VEXAS syndrome by a causal machine learning tool CauNagi

VEXAS syndrome is an adult-onset severe autoinflammatory disease caused by somatic mutations in UBA1, yet the cascade mechanisms linking primitive hematopoietic abnormalities to mature myeloid dysfunctions remain largely unknown. Identifying master regulators of a progressive disease, a black-box process, from complex transcriptomic data also remains challenging. To address this challenge, we developed CauNagi, a computational framework for prioritizing cascade candidate regulators (CCRs). CauNagi integrates a causal representation learning module derived from CausCell with an iterative deep learning backbone adapted from UNAGI; in addition, CauNagi extends these two components with a unique downstream module for CCRs analysis designed to characterize regulatory propagation across hierarchical cellular states. Mechanistically, CauNagi iteratively integrates causal disentangled representation learning with (1) disease-stage cell-state trajectory reconstruction and (2) dynamic regulatory analysis. Benchmarking on single-cell transcriptomic datasets showed that CauNagi preserved cell-type structure in idiopathic pulmonary fibrosis (IPF) and enriched known acute myeloid leukemia(AML)-associated genes among its top-ranked global regulators. When applied to VEXAS syndrome, CauNagi readily revealed inflammatory responses, endoplasmic reticulum stress, and myeloid bias, consistent with the disease features. Furthermore, the CCRs analysis module of CauNagi assisted us in identifying 36 causal drivers, with SPI1, NFKB1, STAT3, and FOS prioritized as high-confidence regulatory hubs linking aberrant myeloid differentiation and inflammatory programs. These findings were further supported by an independent single-cell transcriptomic dataset from a murine VEXAS model. Overall, CauNagi provides a computationally efficient and systematic framework for identifying candidate causal regulators. Beyond hematopoietic diseases, CauNagi may also be applicable to other progressive disorders for which multistage single-cell transcriptomic datasets are available. CauNagi is available at https://github.com/steamed-stuffed-bun/CauNagi.

bioinformatics↗

Inferential boundaries of age prediction: why prediction does not establish biological age measurement

Chronological-age clocks reconstruct age from biological measurements, yet their outputs are interpreted as biological age, gaps as ageing acceleration and intervention-associated decreases as rejuvenation. We show that age supervision identifies an age-task statistic, not a biological-age construct, and establish how this distinction changes biomarker construction and validation. Even at the population optimum, the same observable distribution and age-prediction performance admit incompatible biological-age interpretations. Resolving this ambiguity requires assumptions or evidence beyond the age task. Squared-error age loss penalizes within-age output dispersion without defining its biological direction. Given age and background, a gap re-expresses the compressed score; exact age recovery eliminates it even when heterogeneity remains in the measurements. Shared biological covariance permits genuine prognostic value without establishing construct identity. After allogeneic haematopoietic stem-cell transplantation, recipient-blood scores showed excess donor-lineage affiliation under a score-pairing null. In NHANES, age-trained scores improved held-out five-year mortality prediction beyond age and background, yet direct modelling of source measurements and mortality supervision at matched scalar capacity yielded further gains. The intended biological object must therefore guide study design, measurement selection and representation; validation must establish the claimed measurement relation rather than rely on age-prediction success alone.

bioinformatics↗

DisenTE: Sparse Pattern-Context Modeling for Interpretable Translation-Efficiency Matrix Completion

Partially observed object-by-context matrices arise across data-rich science, where dominant object effects can obscure smaller but informative context-dependent variation. We study this problem in a translation-efficiency atlas of 9,494 5' UTRs across 78 cellular and tissue contexts. We present DisenTE, a sequence-conditioned neural model that combines separate sequence and context branches with a sparse low-rank pattern-context channel. Each module pairs a sequence-derived activation with context-specific deployment weights, forming a dictionary whose sequence and context components can be examined separately. Under five-fold within-panel entry masking, DisenTE achieves a UTR-centered residual Spearman correlation of 0.641 +/- 0.005, compared with 0.304 +/- 0.003 for the strongest reference model. The learned dictionary retains 11 of 20 candidate modules. CTM 6 has the largest overlap with an external TOP set and a cap-proximal pyrimidine pattern; CTMs 5 and 7 also overlap the set but have purine-containing consensuses. The evidence supports CTM 6 as a TOP sequence anchor and CTMs 5 and 7 as TOP-set-associated factors. On this dataset, DisenTE improves completion over the evaluated references and provides module-level summaries of its fitted context-dependent variation.

bioinformatics↗